SlideShare a Scribd company logo
1 of 22
Download to read offline
Incidence of Malignant Ovarian
Germ Cell Tumors (MOGCTs) in
Saudi Arabia
Ahmed Abu-Zaid, MBBS
Alfaisal University―College of Medicine
King Faisal Specialist Hospital & Research Centre
Riyadh, Saudi Arabia
Hematol Oncol Stem Cell Ther. 2014 Mar;7(1):41-3
INTRODUCTION
 Ovarian Germ Cell Tumors (OGCT)
– Originate from primitive ovarian germ cells
– Rapidly growing tumors
– Frequent in young women and adolescent girls
– Uncommon, 20-25% of all ovarian tumors
– Pathologically: benign or malignant
Gershenson DM. Cancer. 1993;71(4 Suppl):1581-90
Siegel R, et al. CA Cancer J Clin. 2013; 63:11–30
INTRODUCTION
 Malignant Ovarian Germ Cell Tumors (MOGCTs)
―Uncommon, 5% of all malignant ovarian tumors
―Histopathological classification
Gershenson DM. Cancer. 1993;71(4 Suppl):1581-90
Dysgerminoma Yolk Sac Tumor
Germinoma Malignant Teratoma
Polyembryoma Ovarian Choriocarcinoma
Embryonal Carcinoma Mixed Germ Cell Tumor
Siegel R, et al. CA Cancer J Clin. 2013; 63:11–30
OBJECTIVE
 Define the population-based incidence and
histopathological types of MOGCTs in the Saudi
Arabian population from 1999 to 2008
MATERIALS AND METHODS
 Saudi Cancer Registry (SCR)
—Cross-sectional study
—Jan. 1999 to Dec. 2008
—MOGCT epidemiological data
o Histopathological types
o Frequency of cases
o Crude Incidence Rates (CIRs)
o Age-Standardized Incidence Rates (ASIRs)
SCR. https://scr.clearvision.com.sa
Freedman D, et al. Statistics. 1997. ISBN-10: 0393970833
RESULTS
 Figure 1
Incidence of Female, Ovarian and MOGCTs
All Female Tumors = 30,720
All Ovarian Tumors = 1,271
Incidence = 4.1% (n= 1,271/30,720)
All MOGCTs = 175
Incidence = 13.8% (n= 175/1,271)
RESULTS
 Figure 2
Histopathological types of MOGCTs
41%
25%
19%
14%
1%
Dysgerminoma
Malignant Teratoma
Yolk Sac Tumor
Mixed Germ Cell Tumor
Embryonal Carcinoma
RESULTS
 Table 1
Incidence of MOGCTs per year
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 Total (%)
10 7 5 5 8 4 9 8 10 6 72 (41.1)
0 0 0 2 0 0 0 0 0 0 2 (1.1)
2 2 3 6 4 4 2 1 2 6 32 (18.3)
5 7 5 5 6 3 1 2 6 4 44 (25.1)
4 2 1 1 4 2 4 4 1 2 25 (14.3)
21
(12)
18
(10.3)
14
(8.0)
19
(10.9)
22
(12.6)
13
(7.4)
16
(9.1)
15
(8.6)
19
(10.9)
18
(10.3)
175 (100)
RESULTS
 Table 2
Total number of cases, CIRs and world ASIRs
Year All Ages 0-24 25-39 40+ CIR ASIR p
1999 21 14 6 1 0.3 0.3 NS
2000 18 13 3 2 0.2 0.2 NS
2001 14 9 3 2 0.2 0.2 NS
2002 19 13 2 4 0.2 0.2 NS
2003 22 17 5 0 0.3 0.2 NS
2004 13 9 2 2 0.2 0.1 NS
2005 16 14 2 0 0.2 0.1 NS
2006 15 10 4 1 0.2 0.2 NS
2007 19 17 1 1 0.2 0.2 NS
2008 18 14 5 0 0.2 0.2 NS
Total (%) 175 (100) 130 (74.3) 33 (18.9) 12 (6.9)
DISCUSSION
 Incidence of All Ovarian Tumors
Siegel R, et al. CA Cancer J Clin. 2013; 63: 11–30
Saudi Arabia West
All Female-Related Tumors 4.1% 3%
DISCUSSION
 Incidence of All MOGCTs
Saudi Arabia West Asia and Africa
13.8% 5% 15%
Low JJ, et al. Best Pract Res Clin Obstet Gynaecol. 2012; 26: 347–55
DISCUSSION
 Incidence of Dysgerminoma
―Most frequent histopathological type
Saudi Arabia Worldwide
All Ovarian Tumors 5.7% 2%
All MOGCTs 41.1% 35-50%
Gershenson DM. Cancer. 1993; 71: 1581–90
Chen VW, et al. Cancer. 2003; 97: 2631–42
DISCUSSION
 Incidence of Malignant Teratomas
―Second most frequent histopathological type
Saudi Arabia Worldwide
All Ovarian Tumors 3.5% < 1%
All MOGCTs 25.1% 20%
Deodhar KK, et al. Indian J Pathol Microbiol. 2011; 54: 730–5
DISCUSSION
 Incidence of Yolk Sac Tumors
―Third most frequent histopathological type
Saudi Arabia Worldwide
All MOGCTs 18.3% 20%
Gershenson DM. Cancer. 1993; 71: 1581–90
DISCUSSION
 Incidence of Mixed Germ Cell Tumors
―Fourth most frequent histopathological type
Saudi Arabia Worldwide
All MOGCTs 14.3% 10%
Gershenson DM. Cancer. 1993; 71: 1581–90
DISCUSSION
 Incidence of Polyembryoma & Primary Ovarian
Choriocarcinomas
―Mostly exist in admixed forms
Saudi Arabia Worldwide
All MOGCTs 0% < 1%
Gershenson DM. Cancer. 1993; 71: 1581–90
Tewari K, et al. Obstet Gynecol. 2000; 95: 128–33
DISCUSSION
 Median age of MOGCTs
― 74% of cases occurred between 0 and 25 years
― Younger age group of Saudi population
― Fertility and its challenge to gynecologic oncologists
Saudi Arabia Worldwide
Median Age (years) 18 18
Williams SD, et al. Principles and practice of gynecologic oncology. 1997: 987–1002
Gershenson DM. Gynecol Oncol. 1994; 55: S62–S72
STUDY LIMITATIONS
 Clinico-Pathological details are not explored
― Beyond the scope of study
― Will be Addressed in a future study
CONCLUSION
 First Saudi study exploring incidence of MOGCTs
 MOGCTs
― Common tumors (15.8%)
― Mostly in child-bearing women
― Incidence rates and histopathological types are
similar to international populations with few
differences
Future Studies
 Detailed Single-Center Experience at KFSH&RC
― Epidemiology/Risk factors
― Clinical Presentation
― Tumor biological behavior
― Blood markers/Imaging modalities
― Management modalities
― Prognosis
AKNOLWEDGMENT
 Ahmed Nazer, MD
 Osama AlOmar, MD
 Ayman Azzam, MD, PhD
 Haya S. Al-Eid, MD
 Tusneem A. Elhassan, PhD
 Ismail A. Al-Badawi, MD, FRCSC
THANK YOU
THANK YOU

More Related Content

What's hot

Epidemiology of cancer
Epidemiology of cancer Epidemiology of cancer
Epidemiology of cancer suhas k r
 
HCC in the Arab World Final
 HCC in the Arab World Final HCC in the Arab World Final
HCC in the Arab World FinalPAIRS WEB
 
Introduction to cancer epidemiology basics mr es021012
Introduction to cancer epidemiology basics mr es021012Introduction to cancer epidemiology basics mr es021012
Introduction to cancer epidemiology basics mr es021012Portobellochris
 
Cancer epidemiology
Cancer epidemiologyCancer epidemiology
Cancer epidemiologyNayyar Kazmi
 
Epidemiology of cancer
Epidemiology of cancerEpidemiology of cancer
Epidemiology of cancerDOCTOR WHO
 
The incidence of significant lesions on cervical smears poster final edit
The incidence of significant lesions on cervical smears  poster final editThe incidence of significant lesions on cervical smears  poster final edit
The incidence of significant lesions on cervical smears poster final editGenevieve Warner Learmonth
 
breast and prostate cancer.
breast and prostate cancer.breast and prostate cancer.
breast and prostate cancer.Ameenah
 
Cervical cancerin ksa dec 2011
Cervical cancerin ksa dec 2011Cervical cancerin ksa dec 2011
Cervical cancerin ksa dec 2011Tariq Mohammed
 
Cancer detection therapy
Cancer detection therapyCancer detection therapy
Cancer detection therapyWalt Whitman
 
Global lung cancer vaccine market & pipeline insight 2015
Global lung cancer vaccine market & pipeline insight 2015Global lung cancer vaccine market & pipeline insight 2015
Global lung cancer vaccine market & pipeline insight 2015KuicK Research
 
Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...
Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...
Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...Enrique Moreno Gonzalez
 

What's hot (19)

Epidemiology of cancer
Epidemiology of cancer Epidemiology of cancer
Epidemiology of cancer
 
Cancer scenario in Kashmir.
Cancer scenario in Kashmir. Cancer scenario in Kashmir.
Cancer scenario in Kashmir.
 
HCC in the Arab World Final
 HCC in the Arab World Final HCC in the Arab World Final
HCC in the Arab World Final
 
Cancer Epidemiology part I
Cancer Epidemiology part ICancer Epidemiology part I
Cancer Epidemiology part I
 
Esmo 2010 Powerpoint Slides
Esmo 2010 Powerpoint SlidesEsmo 2010 Powerpoint Slides
Esmo 2010 Powerpoint Slides
 
Introduction to cancer epidemiology basics mr es021012
Introduction to cancer epidemiology basics mr es021012Introduction to cancer epidemiology basics mr es021012
Introduction to cancer epidemiology basics mr es021012
 
Cancer epidemiology
Cancer epidemiologyCancer epidemiology
Cancer epidemiology
 
Gi tumour
Gi tumourGi tumour
Gi tumour
 
Epidemiology of cancer
Epidemiology of cancerEpidemiology of cancer
Epidemiology of cancer
 
The incidence of significant lesions on cervical smears poster final edit
The incidence of significant lesions on cervical smears  poster final editThe incidence of significant lesions on cervical smears  poster final edit
The incidence of significant lesions on cervical smears poster final edit
 
Cancer Statistics
Cancer StatisticsCancer Statistics
Cancer Statistics
 
breast and prostate cancer.
breast and prostate cancer.breast and prostate cancer.
breast and prostate cancer.
 
Cervical cancerin ksa dec 2011
Cervical cancerin ksa dec 2011Cervical cancerin ksa dec 2011
Cervical cancerin ksa dec 2011
 
Breast cancer myth and facts
Breast cancer myth and factsBreast cancer myth and facts
Breast cancer myth and facts
 
Cancer detection therapy
Cancer detection therapyCancer detection therapy
Cancer detection therapy
 
Global lung cancer vaccine market & pipeline insight 2015
Global lung cancer vaccine market & pipeline insight 2015Global lung cancer vaccine market & pipeline insight 2015
Global lung cancer vaccine market & pipeline insight 2015
 
CANCER CERVIX BURDEN OF HPV
CANCER CERVIX BURDEN OF HPVCANCER CERVIX BURDEN OF HPV
CANCER CERVIX BURDEN OF HPV
 
Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...
Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...
Alterations of the genes involved in the PI3K and estrogen-receptor pathways ...
 
Cancer Statistics 2006 Presentation
Cancer Statistics 2006 PresentationCancer Statistics 2006 Presentation
Cancer Statistics 2006 Presentation
 

Viewers also liked

MCO 2011 - Slide 13 - J.B. Vermorken - Ovarian cancer
MCO 2011 - Slide 13 - J.B. Vermorken - Ovarian cancerMCO 2011 - Slide 13 - J.B. Vermorken - Ovarian cancer
MCO 2011 - Slide 13 - J.B. Vermorken - Ovarian cancerEuropean School of Oncology
 
Nhận xét đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị ung thư buồng tr...
Nhận xét đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị ung thư buồng tr...Nhận xét đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị ung thư buồng tr...
Nhận xét đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị ung thư buồng tr...Luanvanyhoc.com-Zalo 0927.007.596
 
NHẬN XÉT MỘT SỐ ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ ĐIỀU TRỊ U BUỒNG TRỨNG THỂ...
NHẬN XÉT MỘT SỐ ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ ĐIỀU TRỊ U BUỒNG TRỨNG THỂ...NHẬN XÉT MỘT SỐ ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ ĐIỀU TRỊ U BUỒNG TRỨNG THỂ...
NHẬN XÉT MỘT SỐ ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ ĐIỀU TRỊ U BUỒNG TRỨNG THỂ...Luanvanyhoc.com-Zalo 0927.007.596
 
NHẬN XÉT ĐẶC ĐIỂM LÂM SÀNG, MÔ BỆNH HỌC VÀ KẾT QUẢ ĐIỀU TRỊ UNG THƯ BIỂU MÔ M...
NHẬN XÉT ĐẶC ĐIỂM LÂM SÀNG, MÔ BỆNH HỌC VÀ KẾT QUẢ ĐIỀU TRỊ UNG THƯ BIỂU MÔ M...NHẬN XÉT ĐẶC ĐIỂM LÂM SÀNG, MÔ BỆNH HỌC VÀ KẾT QUẢ ĐIỀU TRỊ UNG THƯ BIỂU MÔ M...
NHẬN XÉT ĐẶC ĐIỂM LÂM SÀNG, MÔ BỆNH HỌC VÀ KẾT QUẢ ĐIỀU TRỊ UNG THƯ BIỂU MÔ M...Luanvanyhoc.com-Zalo 0927.007.596
 
Second line chemotherapy for ovarian cancer
Second line chemotherapy for ovarian cancerSecond line chemotherapy for ovarian cancer
Second line chemotherapy for ovarian cancerBasalama Ali
 
Aurelia asco 20121
Aurelia asco 20121Aurelia asco 20121
Aurelia asco 20121lefein
 
Pelvic mass of ovarian/adenexal origin
Pelvic mass of ovarian/adenexal originPelvic mass of ovarian/adenexal origin
Pelvic mass of ovarian/adenexal originEzmeer Emiral
 
Dr. Paul Sabbatini: Recurrent Ovarian Cancer: Now What? (SHARE Program)
Dr. Paul Sabbatini: Recurrent Ovarian Cancer: Now What? (SHARE Program)Dr. Paul Sabbatini: Recurrent Ovarian Cancer: Now What? (SHARE Program)
Dr. Paul Sabbatini: Recurrent Ovarian Cancer: Now What? (SHARE Program)bkling
 
Ovarian Tumors, Diagnosis Or Prognosis
Ovarian Tumors, Diagnosis Or PrognosisOvarian Tumors, Diagnosis Or Prognosis
Ovarian Tumors, Diagnosis Or PrognosisGalal Lotfi
 
Prophylactic Cytoreduction and HIPEC
Prophylactic Cytoreduction and HIPECProphylactic Cytoreduction and HIPEC
Prophylactic Cytoreduction and HIPECMichail Papoulas
 
Ovarian surface epithelial cancers; genetic modles
Ovarian surface epithelial cancers; genetic modlesOvarian surface epithelial cancers; genetic modles
Ovarian surface epithelial cancers; genetic modlesimrana tanvir
 
Classification of ovarian tumors
Classification of ovarian tumorsClassification of ovarian tumors
Classification of ovarian tumorsDr Anusha Rao P
 
PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...
PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...
PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...Clinical Care Options
 

Viewers also liked (20)

MCO 2011 - Slide 13 - J.B. Vermorken - Ovarian cancer
MCO 2011 - Slide 13 - J.B. Vermorken - Ovarian cancerMCO 2011 - Slide 13 - J.B. Vermorken - Ovarian cancer
MCO 2011 - Slide 13 - J.B. Vermorken - Ovarian cancer
 
Nhận xét đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị ung thư buồng tr...
Nhận xét đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị ung thư buồng tr...Nhận xét đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị ung thư buồng tr...
Nhận xét đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị ung thư buồng tr...
 
NHẬN XÉT MỘT SỐ ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ ĐIỀU TRỊ U BUỒNG TRỨNG THỂ...
NHẬN XÉT MỘT SỐ ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ ĐIỀU TRỊ U BUỒNG TRỨNG THỂ...NHẬN XÉT MỘT SỐ ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ ĐIỀU TRỊ U BUỒNG TRỨNG THỂ...
NHẬN XÉT MỘT SỐ ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ ĐIỀU TRỊ U BUỒNG TRỨNG THỂ...
 
NHẬN XÉT ĐẶC ĐIỂM LÂM SÀNG, MÔ BỆNH HỌC VÀ KẾT QUẢ ĐIỀU TRỊ UNG THƯ BIỂU MÔ M...
NHẬN XÉT ĐẶC ĐIỂM LÂM SÀNG, MÔ BỆNH HỌC VÀ KẾT QUẢ ĐIỀU TRỊ UNG THƯ BIỂU MÔ M...NHẬN XÉT ĐẶC ĐIỂM LÂM SÀNG, MÔ BỆNH HỌC VÀ KẾT QUẢ ĐIỀU TRỊ UNG THƯ BIỂU MÔ M...
NHẬN XÉT ĐẶC ĐIỂM LÂM SÀNG, MÔ BỆNH HỌC VÀ KẾT QUẢ ĐIỀU TRỊ UNG THƯ BIỂU MÔ M...
 
Second line chemotherapy for ovarian cancer
Second line chemotherapy for ovarian cancerSecond line chemotherapy for ovarian cancer
Second line chemotherapy for ovarian cancer
 
Aurelia asco 20121
Aurelia asco 20121Aurelia asco 20121
Aurelia asco 20121
 
When Cancer Comes Back, Sarah Adams, MD
When Cancer Comes Back, Sarah Adams, MDWhen Cancer Comes Back, Sarah Adams, MD
When Cancer Comes Back, Sarah Adams, MD
 
Pelvic mass of ovarian/adenexal origin
Pelvic mass of ovarian/adenexal originPelvic mass of ovarian/adenexal origin
Pelvic mass of ovarian/adenexal origin
 
Benign ovarian tumors
Benign ovarian tumorsBenign ovarian tumors
Benign ovarian tumors
 
Recist 1.1 2015
Recist 1.1 2015Recist 1.1 2015
Recist 1.1 2015
 
Dr. Paul Sabbatini: Recurrent Ovarian Cancer: Now What? (SHARE Program)
Dr. Paul Sabbatini: Recurrent Ovarian Cancer: Now What? (SHARE Program)Dr. Paul Sabbatini: Recurrent Ovarian Cancer: Now What? (SHARE Program)
Dr. Paul Sabbatini: Recurrent Ovarian Cancer: Now What? (SHARE Program)
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
 
Ovarian tumors I
Ovarian tumors IOvarian tumors I
Ovarian tumors I
 
Ovarian Tumors, Diagnosis Or Prognosis
Ovarian Tumors, Diagnosis Or PrognosisOvarian Tumors, Diagnosis Or Prognosis
Ovarian Tumors, Diagnosis Or Prognosis
 
Adnexal Masses
Adnexal MassesAdnexal Masses
Adnexal Masses
 
Prophylactic Cytoreduction and HIPEC
Prophylactic Cytoreduction and HIPECProphylactic Cytoreduction and HIPEC
Prophylactic Cytoreduction and HIPEC
 
Ovarian surface epithelial cancers; genetic modles
Ovarian surface epithelial cancers; genetic modlesOvarian surface epithelial cancers; genetic modles
Ovarian surface epithelial cancers; genetic modles
 
Classification of ovarian tumors
Classification of ovarian tumorsClassification of ovarian tumors
Classification of ovarian tumors
 
Ovarian Cancer
Ovarian CancerOvarian Cancer
Ovarian Cancer
 
PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...
PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...
PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...
 

Similar to Ahmed abu zaid (final)

Doxorubicin versus Idarubicin with Overall Survival in Adult Acute Myeloid Le...
Doxorubicin versus Idarubicin with Overall Survival in Adult Acute Myeloid Le...Doxorubicin versus Idarubicin with Overall Survival in Adult Acute Myeloid Le...
Doxorubicin versus Idarubicin with Overall Survival in Adult Acute Myeloid Le...Hemat Elgohary
 
Five years treatment outcomes of postoperative radiotherapy in
Five years treatment outcomes of postoperative radiotherapy inFive years treatment outcomes of postoperative radiotherapy in
Five years treatment outcomes of postoperative radiotherapy inBasalama Ali
 
Dr. basem aldeek some%final epidemiological aspects about cancer in king saud...
Dr. basem aldeek some%final epidemiological aspects about cancer in king saud...Dr. basem aldeek some%final epidemiological aspects about cancer in king saud...
Dr. basem aldeek some%final epidemiological aspects about cancer in king saud...Tariq Mohammed
 
Dr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last versionDr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last versionTariq Mohammed
 
Detailed study of epi ov ca in saudi
Detailed study of epi ov ca in saudiDetailed study of epi ov ca in saudi
Detailed study of epi ov ca in saudiBasalama Ali
 
Conservative management of ovarian cancer 14 5-2015
Conservative management of ovarian cancer 14 5-2015Conservative management of ovarian cancer 14 5-2015
Conservative management of ovarian cancer 14 5-2015Basalama Ali
 
Gastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET managementGastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET managementChandan K Das
 
7- hesham sait - gtd final new
 7- hesham sait - gtd final new 7- hesham sait - gtd final new
7- hesham sait - gtd final newBasalama Ali
 
空氣汙染引起 EGFR基因突變肺癌
空氣汙染引起 EGFR基因突變肺癌空氣汙染引起 EGFR基因突變肺癌
空氣汙染引起 EGFR基因突變肺癌celinia
 
Ultrasonography Diagnosis of Scrotal Pathologies
Ultrasonography Diagnosis of Scrotal PathologiesUltrasonography Diagnosis of Scrotal Pathologies
Ultrasonography Diagnosis of Scrotal Pathologiesiosrphr_editor
 
Grail-CCGA-2021-11.pptx
Grail-CCGA-2021-11.pptxGrail-CCGA-2021-11.pptx
Grail-CCGA-2021-11.pptxssuserfffc9c
 
Survival data for crc and screening recommendations (surgery conference)
Survival data for crc and screening recommendations (surgery conference)Survival data for crc and screening recommendations (surgery conference)
Survival data for crc and screening recommendations (surgery conference)Tariq Mohammed
 
Is there a role for ovarian cancer screening
Is there a role for ovarian cancer screeningIs there a role for ovarian cancer screening
Is there a role for ovarian cancer screeningMing Cheng
 
Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Lifecare Centre
 

Similar to Ahmed abu zaid (final) (20)

Doxorubicin versus Idarubicin with Overall Survival in Adult Acute Myeloid Le...
Doxorubicin versus Idarubicin with Overall Survival in Adult Acute Myeloid Le...Doxorubicin versus Idarubicin with Overall Survival in Adult Acute Myeloid Le...
Doxorubicin versus Idarubicin with Overall Survival in Adult Acute Myeloid Le...
 
Five years treatment outcomes of postoperative radiotherapy in
Five years treatment outcomes of postoperative radiotherapy inFive years treatment outcomes of postoperative radiotherapy in
Five years treatment outcomes of postoperative radiotherapy in
 
Dr. basem aldeek some%final epidemiological aspects about cancer in king saud...
Dr. basem aldeek some%final epidemiological aspects about cancer in king saud...Dr. basem aldeek some%final epidemiological aspects about cancer in king saud...
Dr. basem aldeek some%final epidemiological aspects about cancer in king saud...
 
1222222
12222221222222
1222222
 
Dr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last versionDr nisreen anfnan cervical cancer in saudi arabia last version
Dr nisreen anfnan cervical cancer in saudi arabia last version
 
Detailed study of epi ov ca in saudi
Detailed study of epi ov ca in saudiDetailed study of epi ov ca in saudi
Detailed study of epi ov ca in saudi
 
Conservative management of ovarian cancer 14 5-2015
Conservative management of ovarian cancer 14 5-2015Conservative management of ovarian cancer 14 5-2015
Conservative management of ovarian cancer 14 5-2015
 
CANCER PREVENTION & SCREENING IN INDIA.ppt
CANCER PREVENTION & SCREENING IN INDIA.pptCANCER PREVENTION & SCREENING IN INDIA.ppt
CANCER PREVENTION & SCREENING IN INDIA.ppt
 
Gastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET managementGastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET management
 
Radiation Therapy Bc
Radiation Therapy BcRadiation Therapy Bc
Radiation Therapy Bc
 
7- hesham sait - gtd final new
 7- hesham sait - gtd final new 7- hesham sait - gtd final new
7- hesham sait - gtd final new
 
Khartoum feb 2008
Khartoum feb 2008Khartoum feb 2008
Khartoum feb 2008
 
Ki-67 Immunostaining_Breast_Carcinoma_Correlation_Grade_Tumor_Lymph_Node.pdf
Ki-67 Immunostaining_Breast_Carcinoma_Correlation_Grade_Tumor_Lymph_Node.pdfKi-67 Immunostaining_Breast_Carcinoma_Correlation_Grade_Tumor_Lymph_Node.pdf
Ki-67 Immunostaining_Breast_Carcinoma_Correlation_Grade_Tumor_Lymph_Node.pdf
 
空氣汙染引起 EGFR基因突變肺癌
空氣汙染引起 EGFR基因突變肺癌空氣汙染引起 EGFR基因突變肺癌
空氣汙染引起 EGFR基因突變肺癌
 
A05060104
A05060104A05060104
A05060104
 
Ultrasonography Diagnosis of Scrotal Pathologies
Ultrasonography Diagnosis of Scrotal PathologiesUltrasonography Diagnosis of Scrotal Pathologies
Ultrasonography Diagnosis of Scrotal Pathologies
 
Grail-CCGA-2021-11.pptx
Grail-CCGA-2021-11.pptxGrail-CCGA-2021-11.pptx
Grail-CCGA-2021-11.pptx
 
Survival data for crc and screening recommendations (surgery conference)
Survival data for crc and screening recommendations (surgery conference)Survival data for crc and screening recommendations (surgery conference)
Survival data for crc and screening recommendations (surgery conference)
 
Is there a role for ovarian cancer screening
Is there a role for ovarian cancer screeningIs there a role for ovarian cancer screening
Is there a role for ovarian cancer screening
 
Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013
 

More from Basalama Ali

محاضرة التقرير السنوي
محاضرة التقرير السنويمحاضرة التقرير السنوي
محاضرة التقرير السنويBasalama Ali
 
Hpv prevelance and distribution amoung saudi
Hpv prevelance and distribution amoung saudi Hpv prevelance and distribution amoung saudi
Hpv prevelance and distribution amoung saudi Basalama Ali
 
Rmi roma calculator
Rmi roma calculatorRmi roma calculator
Rmi roma calculatorBasalama Ali
 
Dr. anwar moria vulvar warts
Dr. anwar moria   vulvar wartsDr. anwar moria   vulvar warts
Dr. anwar moria vulvar wartsBasalama Ali
 
Cervical screening , present past crown plaza final copy
Cervical screening , present past crown plaza  final copyCervical screening , present past crown plaza  final copy
Cervical screening , present past crown plaza final copyBasalama Ali
 
Fertility preservation 3
Fertility preservation 3Fertility preservation 3
Fertility preservation 3Basalama Ali
 
Prof james bently endometrial ca generalist
Prof james bently   endometrial ca generalistProf james bently   endometrial ca generalist
Prof james bently endometrial ca generalistBasalama Ali
 
The 1 scientific meeting of cancer care for general gynecology
The 1 scientific meeting of cancer care for general gynecologyThe 1 scientific meeting of cancer care for general gynecology
The 1 scientific meeting of cancer care for general gynecologyBasalama Ali
 
Fertility drugs &amp; oa ca ksa fv1
Fertility drugs &amp; oa ca ksa fv1Fertility drugs &amp; oa ca ksa fv1
Fertility drugs &amp; oa ca ksa fv1Basalama Ali
 
Gtd crown plaza 2015
Gtd crown plaza 2015Gtd crown plaza 2015
Gtd crown plaza 2015Basalama Ali
 
Prof bently 3 managing unsuspected ovarian cancer
Prof bently 3 managing unsuspected ovarian cancerProf bently 3 managing unsuspected ovarian cancer
Prof bently 3 managing unsuspected ovarian cancerBasalama Ali
 
Ov ca prevention jeddah
Ov ca prevention jeddahOv ca prevention jeddah
Ov ca prevention jeddahBasalama Ali
 
1- prof james bently - hpv and vaccine jeddah 2015
 1- prof james bently - hpv and vaccine jeddah 2015 1- prof james bently - hpv and vaccine jeddah 2015
1- prof james bently - hpv and vaccine jeddah 2015Basalama Ali
 
3-perimenopausal bleeding management &amp; rx
 3-perimenopausal bleeding management &amp; rx 3-perimenopausal bleeding management &amp; rx
3-perimenopausal bleeding management &amp; rxBasalama Ali
 
2-medical treatment of endometrial hyperplasia and endometrial cancer
 2-medical treatment of endometrial hyperplasia and endometrial cancer 2-medical treatment of endometrial hyperplasia and endometrial cancer
2-medical treatment of endometrial hyperplasia and endometrial cancerBasalama Ali
 
Second line chemotherapy for ovarian cancer
Second line chemotherapy for ovarian cancerSecond line chemotherapy for ovarian cancer
Second line chemotherapy for ovarian cancerBasalama Ali
 
Targeted therapy in ovarian cancer
Targeted therapy in ovarian cancerTargeted therapy in ovarian cancer
Targeted therapy in ovarian cancerBasalama Ali
 
Screening for ovarian cancer may 15
Screening for ovarian cancer  may 15Screening for ovarian cancer  may 15
Screening for ovarian cancer may 15Basalama Ali
 

More from Basalama Ali (20)

محاضرة التقرير السنوي
محاضرة التقرير السنويمحاضرة التقرير السنوي
محاضرة التقرير السنوي
 
Hpv prevelance and distribution amoung saudi
Hpv prevelance and distribution amoung saudi Hpv prevelance and distribution amoung saudi
Hpv prevelance and distribution amoung saudi
 
Figo risk scoring
Figo risk scoringFigo risk scoring
Figo risk scoring
 
Rmi roma calculator
Rmi roma calculatorRmi roma calculator
Rmi roma calculator
 
Dr. anwar moria vulvar warts
Dr. anwar moria   vulvar wartsDr. anwar moria   vulvar warts
Dr. anwar moria vulvar warts
 
Cervical screening , present past crown plaza final copy
Cervical screening , present past crown plaza  final copyCervical screening , present past crown plaza  final copy
Cervical screening , present past crown plaza final copy
 
Fertility preservation 3
Fertility preservation 3Fertility preservation 3
Fertility preservation 3
 
Prof james bently endometrial ca generalist
Prof james bently   endometrial ca generalistProf james bently   endometrial ca generalist
Prof james bently endometrial ca generalist
 
The 1 scientific meeting of cancer care for general gynecology
The 1 scientific meeting of cancer care for general gynecologyThe 1 scientific meeting of cancer care for general gynecology
The 1 scientific meeting of cancer care for general gynecology
 
Fertility drugs &amp; oa ca ksa fv1
Fertility drugs &amp; oa ca ksa fv1Fertility drugs &amp; oa ca ksa fv1
Fertility drugs &amp; oa ca ksa fv1
 
Gtd crown plaza 2015
Gtd crown plaza 2015Gtd crown plaza 2015
Gtd crown plaza 2015
 
Prof bently 3 managing unsuspected ovarian cancer
Prof bently 3 managing unsuspected ovarian cancerProf bently 3 managing unsuspected ovarian cancer
Prof bently 3 managing unsuspected ovarian cancer
 
Ov ca prevention jeddah
Ov ca prevention jeddahOv ca prevention jeddah
Ov ca prevention jeddah
 
Pap maneg
Pap manegPap maneg
Pap maneg
 
1- prof james bently - hpv and vaccine jeddah 2015
 1- prof james bently - hpv and vaccine jeddah 2015 1- prof james bently - hpv and vaccine jeddah 2015
1- prof james bently - hpv and vaccine jeddah 2015
 
3-perimenopausal bleeding management &amp; rx
 3-perimenopausal bleeding management &amp; rx 3-perimenopausal bleeding management &amp; rx
3-perimenopausal bleeding management &amp; rx
 
2-medical treatment of endometrial hyperplasia and endometrial cancer
 2-medical treatment of endometrial hyperplasia and endometrial cancer 2-medical treatment of endometrial hyperplasia and endometrial cancer
2-medical treatment of endometrial hyperplasia and endometrial cancer
 
Second line chemotherapy for ovarian cancer
Second line chemotherapy for ovarian cancerSecond line chemotherapy for ovarian cancer
Second line chemotherapy for ovarian cancer
 
Targeted therapy in ovarian cancer
Targeted therapy in ovarian cancerTargeted therapy in ovarian cancer
Targeted therapy in ovarian cancer
 
Screening for ovarian cancer may 15
Screening for ovarian cancer  may 15Screening for ovarian cancer  may 15
Screening for ovarian cancer may 15
 

Recently uploaded

18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 

Recently uploaded (20)

18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 

Ahmed abu zaid (final)

  • 1. Incidence of Malignant Ovarian Germ Cell Tumors (MOGCTs) in Saudi Arabia Ahmed Abu-Zaid, MBBS Alfaisal University―College of Medicine King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia Hematol Oncol Stem Cell Ther. 2014 Mar;7(1):41-3
  • 2. INTRODUCTION  Ovarian Germ Cell Tumors (OGCT) – Originate from primitive ovarian germ cells – Rapidly growing tumors – Frequent in young women and adolescent girls – Uncommon, 20-25% of all ovarian tumors – Pathologically: benign or malignant Gershenson DM. Cancer. 1993;71(4 Suppl):1581-90 Siegel R, et al. CA Cancer J Clin. 2013; 63:11–30
  • 3. INTRODUCTION  Malignant Ovarian Germ Cell Tumors (MOGCTs) ―Uncommon, 5% of all malignant ovarian tumors ―Histopathological classification Gershenson DM. Cancer. 1993;71(4 Suppl):1581-90 Dysgerminoma Yolk Sac Tumor Germinoma Malignant Teratoma Polyembryoma Ovarian Choriocarcinoma Embryonal Carcinoma Mixed Germ Cell Tumor Siegel R, et al. CA Cancer J Clin. 2013; 63:11–30
  • 4. OBJECTIVE  Define the population-based incidence and histopathological types of MOGCTs in the Saudi Arabian population from 1999 to 2008
  • 5. MATERIALS AND METHODS  Saudi Cancer Registry (SCR) —Cross-sectional study —Jan. 1999 to Dec. 2008 —MOGCT epidemiological data o Histopathological types o Frequency of cases o Crude Incidence Rates (CIRs) o Age-Standardized Incidence Rates (ASIRs) SCR. https://scr.clearvision.com.sa Freedman D, et al. Statistics. 1997. ISBN-10: 0393970833
  • 6. RESULTS  Figure 1 Incidence of Female, Ovarian and MOGCTs All Female Tumors = 30,720 All Ovarian Tumors = 1,271 Incidence = 4.1% (n= 1,271/30,720) All MOGCTs = 175 Incidence = 13.8% (n= 175/1,271)
  • 7. RESULTS  Figure 2 Histopathological types of MOGCTs 41% 25% 19% 14% 1% Dysgerminoma Malignant Teratoma Yolk Sac Tumor Mixed Germ Cell Tumor Embryonal Carcinoma
  • 8. RESULTS  Table 1 Incidence of MOGCTs per year 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 Total (%) 10 7 5 5 8 4 9 8 10 6 72 (41.1) 0 0 0 2 0 0 0 0 0 0 2 (1.1) 2 2 3 6 4 4 2 1 2 6 32 (18.3) 5 7 5 5 6 3 1 2 6 4 44 (25.1) 4 2 1 1 4 2 4 4 1 2 25 (14.3) 21 (12) 18 (10.3) 14 (8.0) 19 (10.9) 22 (12.6) 13 (7.4) 16 (9.1) 15 (8.6) 19 (10.9) 18 (10.3) 175 (100)
  • 9. RESULTS  Table 2 Total number of cases, CIRs and world ASIRs Year All Ages 0-24 25-39 40+ CIR ASIR p 1999 21 14 6 1 0.3 0.3 NS 2000 18 13 3 2 0.2 0.2 NS 2001 14 9 3 2 0.2 0.2 NS 2002 19 13 2 4 0.2 0.2 NS 2003 22 17 5 0 0.3 0.2 NS 2004 13 9 2 2 0.2 0.1 NS 2005 16 14 2 0 0.2 0.1 NS 2006 15 10 4 1 0.2 0.2 NS 2007 19 17 1 1 0.2 0.2 NS 2008 18 14 5 0 0.2 0.2 NS Total (%) 175 (100) 130 (74.3) 33 (18.9) 12 (6.9)
  • 10. DISCUSSION  Incidence of All Ovarian Tumors Siegel R, et al. CA Cancer J Clin. 2013; 63: 11–30 Saudi Arabia West All Female-Related Tumors 4.1% 3%
  • 11. DISCUSSION  Incidence of All MOGCTs Saudi Arabia West Asia and Africa 13.8% 5% 15% Low JJ, et al. Best Pract Res Clin Obstet Gynaecol. 2012; 26: 347–55
  • 12. DISCUSSION  Incidence of Dysgerminoma ―Most frequent histopathological type Saudi Arabia Worldwide All Ovarian Tumors 5.7% 2% All MOGCTs 41.1% 35-50% Gershenson DM. Cancer. 1993; 71: 1581–90 Chen VW, et al. Cancer. 2003; 97: 2631–42
  • 13. DISCUSSION  Incidence of Malignant Teratomas ―Second most frequent histopathological type Saudi Arabia Worldwide All Ovarian Tumors 3.5% < 1% All MOGCTs 25.1% 20% Deodhar KK, et al. Indian J Pathol Microbiol. 2011; 54: 730–5
  • 14. DISCUSSION  Incidence of Yolk Sac Tumors ―Third most frequent histopathological type Saudi Arabia Worldwide All MOGCTs 18.3% 20% Gershenson DM. Cancer. 1993; 71: 1581–90
  • 15. DISCUSSION  Incidence of Mixed Germ Cell Tumors ―Fourth most frequent histopathological type Saudi Arabia Worldwide All MOGCTs 14.3% 10% Gershenson DM. Cancer. 1993; 71: 1581–90
  • 16. DISCUSSION  Incidence of Polyembryoma & Primary Ovarian Choriocarcinomas ―Mostly exist in admixed forms Saudi Arabia Worldwide All MOGCTs 0% < 1% Gershenson DM. Cancer. 1993; 71: 1581–90 Tewari K, et al. Obstet Gynecol. 2000; 95: 128–33
  • 17. DISCUSSION  Median age of MOGCTs ― 74% of cases occurred between 0 and 25 years ― Younger age group of Saudi population ― Fertility and its challenge to gynecologic oncologists Saudi Arabia Worldwide Median Age (years) 18 18 Williams SD, et al. Principles and practice of gynecologic oncology. 1997: 987–1002 Gershenson DM. Gynecol Oncol. 1994; 55: S62–S72
  • 18. STUDY LIMITATIONS  Clinico-Pathological details are not explored ― Beyond the scope of study ― Will be Addressed in a future study
  • 19. CONCLUSION  First Saudi study exploring incidence of MOGCTs  MOGCTs ― Common tumors (15.8%) ― Mostly in child-bearing women ― Incidence rates and histopathological types are similar to international populations with few differences
  • 20. Future Studies  Detailed Single-Center Experience at KFSH&RC ― Epidemiology/Risk factors ― Clinical Presentation ― Tumor biological behavior ― Blood markers/Imaging modalities ― Management modalities ― Prognosis
  • 21. AKNOLWEDGMENT  Ahmed Nazer, MD  Osama AlOmar, MD  Ayman Azzam, MD, PhD  Haya S. Al-Eid, MD  Tusneem A. Elhassan, PhD  Ismail A. Al-Badawi, MD, FRCSC